Hoersholm, Denmark

Trond Ulven

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 7Tm Pharma A/s. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Trond Ulven. Retrieved from https://idiyas.com/inventor/trond-ulven-915o2egr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Trond Ulven: Innovator in Medicinal Chemistry

Introduction

Trond Ulven is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors for therapeutic uses.

Latest Patents

Trond Ulven holds a patent for "CRTH2 receptor ligands for medicinal uses." This patent describes compounds that are useful for treating diseases responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis. The compounds are characterized by a specific formula that includes various functional groups and ring structures, allowing for targeted therapeutic effects.

Career Highlights

Trond Ulven is associated with 7tm Pharma A/S, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work focuses on innovative solutions for treating allergic conditions and other related diseases.

Collaborations

Trond has collaborated with notable colleagues such as Thomas Frimurer and Øystein Rist, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Trond Ulven's work exemplifies the impact of innovative research in medicinal chemistry. His contributions continue to pave the way for new therapeutic options in treating various allergic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…